Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity

Asia Pacific PoC molecular diagnostics market will grow by 15.1% annually with a total addressable market cap of $8,360.1 million over 2020-2030 owing to the rising adoption of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic.
Highlighted with 34 tables and 52 figures, this 124-page report “Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 2020-2030 by Product (Assays, Instruments, Software), Technology (PCR, INAAT, Microarray), Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific PoC molecular diagnostics market in every aspect of the classification from perspectives of Product, Technology, Application, End User, and Country.

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Kits & Assays
• Analyzers & Instruments
• Software & Services

Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Polymerase Chain Reaction (PCR)
• Real-Time PCR (rt-PCR)
• Digital PCR (d-PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Genetic Sequencing-based Technology
Microarray-based Technology
Other Technologies

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Infectious Disease
• Respiratory Infections
• Hospital Acquired Infections
• Sexually Transmitted Infections
Gastrointestinal Infections
Oncology
Hepatitis
Prenatal/Neonatal Testing
Other Applications

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospitals
• Clinics & Diagnostic Centers
• Research and Academic Institutes
• Other End Users

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific PoC molecular diagnostics market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abacus Diagnostica Oy
Abbott Laboratories
Alere Inc.
Biocartis Group NV
Biomerieux SA
Bio-Rad Laboratories Inc
Danaher Corporation
DiaSorin S.p.A
DxNA LLC.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience Inc.
Mesa Biotech Inc.
QIAGEN N.V.
QuantuMDx Group Ltd.
Quidel Corporation
Spartan Biosciences Inc.
Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porter’s Fiver Forces Analysis 38
3 Segmentation of Asia Pacific Market by Product 43
3.1 Market Overview by Product 43
3.2 Kits & Assays 45
3.3 Analyzers & Instruments 46
3.4 Software & Services 47
4 Segmentation of Asia Pacific Market by Technology 48
4.1 Market Overview by Technology 48
4.2 Polymerase Chain Reaction (PCR) 50
4.2.1 Real-Time PCR (rt-PCR) 51
4.2.2 Digital PCR (d-PCR) 52
4.3 Isothermal Nucleic Acid Amplification Technology (INAAT) 53
4.4 Genetic Sequencing-based Technology 54
4.5 Microarray-based Technology 55
4.6 Other Technologies 56
5 Segmentation of Asia Pacific Market by Application 57
5.1 Market Overview by Application 57
5.2 Infectious Disease 59
5.2.1 Respiratory Infections 61
5.2.2 Hospital Acquired Infections 62
5.2.3 Sexually Transmitted Infections 63
5.3 Gastrointestinal Infections 64
5.4 Oncology 65
5.5 Hepatitis 66
5.6 Prenatal/Neonatal Testing 67
5.7 Other Applications 68
6 Segmentation of Asia Pacific Market by End User 69
6.1 Market Overview by End User 69
6.2 Hospitals 71
6.3 Clinics & Diagnostic Centers 72
6.4 Research and Academic Institutes 73
6.5 Other End Users 74
7 Asia-Pacific Market 2019-2030 by Country 76
7.1 Overview of Asia-Pacific Market 76
7.2 Japan 79
7.3 China 82
7.4 Australia 85
7.5 India 87
7.6 South Korea 89
7.7 Rest of APAC Region 91
8 Competitive Landscape 93
8.1 Overview of Key Vendors 93
8.2 New Product Launch, Partnership, Investment, and M&A 97
8.3 Company Profiles 98
Abacus Diagnostica Oy 98
Abbott Laboratories 100
Alere Inc. 101
Biocartis Group NV 102
Biomerieux SA 103
Bio-Rad Laboratories Inc 104
Danaher Corporation 105
DiaSorin S.p.A 106
DxNA LLC. 107
F. Hoffmann-La Roche Ltd. 108
Hologic, Inc. 109
Luminex Corporation 110
Meridian Bioscience Inc. 111
Mesa Biotech Inc. 112
QIAGEN N.V. 113
QuantuMDx Group Ltd. 114
Quidel Corporation 115
Spartan Biosciences Inc. 116
Thermo Fisher Scientific 117
9 Investing in Asia Pacific Market: Risk Assessment and Management 118
9.1 Risk Evaluation of Asia Pacific Market 118
9.2 Critical Success Factors (CSFs) 121
Related Reports and Products 124

Key Players (this may not be a complete list and extra companies can be added upon request):
Abacus Diagnostica Oy
Abbott Laboratories
Alere Inc.
Biocartis Group NV
Biomerieux SA
Bio-Rad Laboratories Inc
Danaher Corporation
DiaSorin S.p.A
DxNA LLC.
F. Hoffmann-La Roche Ltd.
Hologic, Inc.
Luminex Corporation
Meridian Bioscience Inc.
Mesa Biotech Inc.
QIAGEN N.V.
QuantuMDx Group Ltd.
Quidel Corporation
Spartan Biosciences Inc.
Thermo Fisher Scientific
Table 1. Snapshot of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market, 2019-2030 18
Table 2. Growth Rate of World Real GDP, 2017-2021 22
Table 3. Main Product Trends and Market Opportunities in Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 34
Table 4. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 43
Table 5. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 48
Table 6. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR) by Type, 2019-2030, $ mn 50
Table 7. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 57
Table 8. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease by Type, 2019-2030, $ mn 60
Table 9. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, $ mn 69
Table 10. APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019-2030, $ mn 77
Table 11. Japan Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 81
Table 12. Japan Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 81
Table 13. Japan Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 81
Table 14. China Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 84
Table 15. China Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 84
Table 16. China Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 84
Table 17. Australia Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 86
Table 18. Australia Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 86
Table 19. Australia Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 86
Table 20. India Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 88
Table 21. India Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 88
Table 22. India Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 88
Table 23. South Korea Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, $ mn 90
Table 24. South Korea Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, $ mn 90
Table 25. South Korea Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, $ mn 90
Table 26. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC by Country, 2019-2030, $ mn 92
Table 27. Breakdown of Asia Pacific Market by Key Vendor, 2019, % 95
Table 28. Abacus Diagnostica Oy: Company Snapshot 98
Table 29. Abacus Diagnostica Oy: Business Segmentation 98
Table 30. Abacus Diagnostica Oy: Product Portfolio 99
Table 31. Abacus Diagnostica Oy: Revenue, 2016-2018, $ mn 99
Table 32. Abacus Diagnostica Oy: Recent Developments 99
Table 33. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 119
Table 34. Critical Success Factors and Key Takeaways 122
Figure 1. Research Method Flow Chart 11
Figure 2. Breakdown of Primary Research 13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 17
Figure 5. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market, 2019-2030, $ mn 20
Figure 6. Impact of COVID-19 on Business 24
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 26
Figure 8. World Number of Deaths by Cause in 2017 29
Figure 9. World Number of Deaths from Cancers in 2017 30
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 31
Figure 11. Investment Opportunity Analysis 35
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market 38
Figure 13. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Product, 2019-2030, % of Revenue 43
Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 44
Figure 15. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Kits & Assays, 2019-2030, $ mn 45
Figure 16. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Analyzers & Instruments, 2019-2030, $ mn 46
Figure 17. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Software & Services, 2019-2030, $ mn 47
Figure 18. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Technology, 2019-2030, % of Sales Revenue 48
Figure 19. Asia Pacific Addressable Market Cap in 2020-2030 by Technology, Value ($ mn) and Share (%) 49
Figure 20. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Polymerase Chain Reaction (PCR), 2019-2030, $ mn 50
Figure 21. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Real-Time PCR (rt-PCR), 2019-2030, $ mn 51
Figure 22. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Digital PCR (d-PCR), 2019-2030, $ mn 52
Figure 23. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Isothermal Nucleic Acid Amplification Technology (INAAT), 2019-2030, $ mn 53
Figure 24. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Genetic Sequencing-based Technology, 2019-2030, $ mn 54
Figure 25. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Microarray-based Technology, 2019-2030, $ mn 55
Figure 26. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Other Technologies, 2019-2030, $ mn 56
Figure 27. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by Application, 2019-2030, % of Sales Revenue 57
Figure 28. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 58
Figure 29. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Infectious Disease, 2019-2030, $ mn 59
Figure 30. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Respiratory Infections, 2019-2030, $ mn 61
Figure 31. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Hospital Acquired Infections, 2019-2030, $ mn 62
Figure 32. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Sexually Transmitted Infections, 2019-2030, $ mn 63
Figure 33. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Gastrointestinal Infections, 2019-2030, $ mn 64
Figure 34. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Oncology, 2019-2030, $ mn 65
Figure 35. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Hepatitis, 2019-2030, $ mn 66
Figure 36. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Prenatal/Neonatal Testing, 2019-2030, $ mn 67
Figure 37. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Other Applications, 2019-2030, $ mn 68
Figure 38. Breakdown of Asia Pacific Point of Care (PoC) Molecular Diagnostics Market by End User, 2019-2030, % of Revenue 69
Figure 39. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%) 70
Figure 40. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Hospitals, 2019-2030, $ mn 71
Figure 41. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Clinics & Diagnostic Centers, 2019-2030, $ mn 72
Figure 42. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Research and Academic Institutes, 2019-2030, $ mn 73
Figure 43. Asia Pacific Point of Care (PoC) Molecular Diagnostics Market: Other End Users, 2019-2030, $ mn 74
Figure 44. Breakdown of APAC Point of Care (PoC) Molecular Diagnostics Market by Country, 2019 and 2030, % of Revenue 77
Figure 45. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 78
Figure 46. Point of Care (PoC) Molecular Diagnostics Market in Japan, 2019-2030, $ mn 80
Figure 47. Point of Care (PoC) Molecular Diagnostics Market in China, 2019-2030, $ mn 83
Figure 48. Point of Care (PoC) Molecular Diagnostics Market in Australia, 2019-2030, $ mn 85
Figure 49. Point of Care (PoC) Molecular Diagnostics Market in India, 2019-2030, $ mn 87
Figure 50. Point of Care (PoC) Molecular Diagnostics Market in South Korea, 2019-2030, $ mn 89
Figure 51. Point of Care (PoC) Molecular Diagnostics Market in Rest of APAC, 2019-2030, $ mn 91
Figure 52. Growth Stage of Asia Pacific Point of Care (PoC) Molecular Diagnostics Industry over the Forecast Period 93

Frequently Asked Questions About This Report

Choose License Type

Each market study on Reports Globe will be revised based on COVID-19 impact analysis

How can we help you?

Our salient features

Best Solution

We will help you understand value propositions of various reports across numerous domains and suggest the best possible solution to suffice your research needs.

Customized Research

Our team of analysts and consultants provide assistance for customized research requirements

Max ROI

Guaranteed maximum assistance to help you get your reports at the optimum prices, thereby ensuring maximum returns on investment.

24/7 Support

24X7 availability to help you through the buying process as well as answer any of your doubts.

Our Clients

We've Received Your Request

We Thank You for filling out your requirements. Our sales team will get in touch with you shortly.